Unexplained weight loss (UWL), defined as a loss of more than 5% of body weight within a six to twelve month period without a known cause, can be a harbinger of serious underlying conditions. A comprehensive approach to diagnosing the cause is vital to provide appropriate management and improve patient outcomes.
The first step in the diagnostic approach is a thorough history and physical examination. It's essential to review dietary habits, medication use, psychosocial history, and symptoms suggestive of systemic diseases. The physical examination should focus on signs of malnutrition, wasting syndromes, and systemic diseases.
Initial diagnostic testing should be guided by clues from the history and physical examination. Basic tests include complete blood count, metabolic panel, liver function tests, thyroid function tests, and urinalysis. If these tests are unrevealing, consider targeted testing based on the patient's age, risk factors, and symptoms.
Imaging studies are not routinely recommended unless the history and physical examination suggest a specific disease. In the absence of specific indications, the indiscriminate use of imaging may lead to unnecessary procedures and increased patient anxiety.
In older adults, UWL may be a sign of malignancy, gastrointestinal disorders, or psychiatric conditions. In younger patients, consider endocrine disorders, malabsorption, or chronic infections. Always consider the possibility of eating disorders, especially in adolescents.
Unexplained weight loss can be a challenging diagnostic dilemma. A systematic and comprehensive approach, starting with a detailed history and physical examination, followed by selective diagnostic testing and judicious use of imaging, can effectively elucidate the underlying cause. Understanding the differential diagnosis based on the patient's age and risk factors can help guide the diagnostic approach and lead to timely and appropriate management.
1.
For MDS-Related Anemia, Telomerase Inhibitor Approved.
2.
Efficacy and safety of intravenous chemotherapy in children with intraocular retinoblastoma
3.
Admissions, medical schools, costs, and eligibility requirements information for FNB Onco-Anesthesia.
4.
Treating Depression: Crucial for Recovery From Fibromyalgia
5.
In postmenopausal women with hormone receptor-positive tumors, obesity increases the risk of breast cancer recurrence.
1.
Empowering Oncology with Data: Cloud Security, Real-World Evidence, and Clinical Insights
2.
Immune Regulation of Blood Cell Development
3.
Exploring the Effects of Radiation Therapy on Cystitis: A Journey to Better Health
4.
Transformative Frameworks in Oncology for Better Care
5.
Liposomal Doxorubicin and Mitomycin in Modern Cancer Treatment
1.
International Conference on Oncology, Cancer Prevention and Public Health
2.
International Conference on Cancer Nursing and Rehabilitation Strategies
3.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
4.
International Conference on Innovations in Critical Care for Oncology and Cardiology
5.
International Symposium on Oncology, Cardiology and Critical Care Innovations
1.
Targeting Oncologic Drivers: A New Approach to Lung Cancer Treatment
2.
Newer Immunotherapies for Myeloma- A Comprehensive Overview
3.
Understanding the causes of anemia in adults beyond nutritional deficiencies
4.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part III
5.
Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation